Kobe, Japan

Tokiko Asami

USPTO Granted Patents = 6 

 

 

Average Co-Inventor Count = 5.7

ph-index = 1

Forward Citations = 4(Granted Patents)


Location History:

  • Hyogo, JP (2018)
  • Kobe, JP (2014 - 2020)

Company Filing History:


Years Active: 2014-2020

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Tokiko Asami

Introduction

Tokiko Asami is a prominent inventor based in Kobe, Japan. She has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds for medical applications. With a total of 6 patents to her name, her work continues to impact the industry.

Latest Patents

Among her latest patents are the oxoisoquinoline derivatives, which include a compound that is effective in treating B-cell lymphoma. This compound can be administered as a pharmaceutical composition or a pharmaceutically acceptable salt. Another notable patent is for a furanone derivative, which aims to provide a novel medicine. This derivative is characterized by a specific chemical formula that allows for various substitutions, enhancing its potential therapeutic applications.

Career Highlights

Tokiko Asami has worked with several reputable companies, including Carna Biosciences, Inc. and Sbi Biotech Co., Ltd. Her experience in these organizations has allowed her to refine her skills and contribute to groundbreaking research in the pharmaceutical field.

Collaborations

Throughout her career, Tokiko has collaborated with notable professionals, including Masaaki Sawa and Takayuki Irie. These collaborations have fostered innovation and have been instrumental in advancing her research projects.

Conclusion

Tokiko Asami's contributions to the field of pharmaceuticals through her innovative patents and collaborations highlight her role as a leading inventor. Her work continues to pave the way for advancements in medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…